G100S (p.Gly100Ser) variant of KRT3 (Keratin, type II cytoskeletal 3)

G100S (p.Gly100Ser) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from ClinVar and UniProt describe it as conflicting interpretations in the context of not provided; not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data and structural context.

G100S (p.Gly100Ser) variant details